The article reports on the investigation of RNA interference (RNAi) patents in the United States. Sirna Therapeutics Inc. collected all the RNAi patents in existence since it started in Boulder, Colorado. Sirna has since sold its business to Merck of Whitehouse Station, New Jersey. The therapeutic potential of RNAi is unknown but it has become invaluable in research.